Jaguar Health, Inc. (JAGX) Earnings History
Annual and quarterly earnings data from 2014 to 2025
Loading earnings history...
JAGX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
JAGX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 67.2% | -398.8% | -465.4% |
| 2024 | 83.3% | -263.8% | -329.3% |
| 2023 | 79.1% | -351.3% | -423.1% |
| 2022 | 83.1% | -287.8% | -396.9% |
| 2021 | 46.2% | -939.1% | -1213.3% |
Download Data
Export JAGX earnings history in CSV or JSON format
Free sign-in required to download data
Jaguar Health, Inc. (JAGX) Earnings Overview
As of May 8, 2026, Jaguar Health, Inc. (JAGX) reported trailing twelve-month net income of -$54M, reflecting +82.4% year-over-year growth. The company earned $-803.95 per diluted share over the past four quarters, with a net profit margin of -465.4%.
Looking at the long-term picture, JAGX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9M in fiscal 2014.
Jaguar Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PRGO (-$1.82B net income, -33.5% margin), PAHC ($92M net income, 3.7% margin), SUPN (-$29M net income, -5.4% margin), JAGX has room to improve margins relative to the peer group. Compare JAGX vs PRGO →
JAGX Earnings vs Peers
Earnings metrics vs comparable public companies
JAGX Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$54M | -39.2% | -$46M | $-803.95 | -465.4% | -398.8% |
| 2024 | -$38M | +6.8% | -$31M | $-4574.15 | -329.3% | -263.8% |
| 2023 | -$41M | +13.0% | -$34M | $-93975.00 | -423.1% | -351.3% |
| 2022 | -$47M | +9.8% | -$34M | $-999999.00 | -396.9% | -287.8% |
| 2021 | -$53M | -55.6% | -$41M | $-999999.00 | -1213.3% | -939.1% |
| 2020 | -$34M | +12.3% | -$27M | $-999999.00 | -360.2% | -283.9% |
| 2019 | -$39M | -19.9% | -$29M | $-999999.00 | -667.3% | -501.3% |
| 2018 | -$32M | -46.3% | -$31M | $-999999.00 | -727.9% | -698.0% |
| 2017 | -$22M | -49.1% | -$34M | $-999999.00 | -503.7% | -785.3% |
| 2016 | -$15M | +9.6% | -$14M | $-999999.00 | -10410.9% | -9599.8% |
See JAGX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs JAGX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare JAGX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonJAGX — Frequently Asked Questions
Quick answers to the most common questions about buying JAGX stock.
Is JAGX growing earnings?
JAGX EPS is $-803.95, with earnings growth accelerating to +82.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-54M.
What are JAGX's profit margins?
Jaguar Health, Inc. net margin is -465.4%, with operating margin at -398.8%. Below-average margins reflect competitive or cost pressures.
How consistent are JAGX's earnings?
JAGX earnings data spans 2014-2025. The accelerating earnings trend is +82.4% YoY. Historical data enables comparison across business cycles.